The need for antiemetic drugs, which help prevent or relieve nausea and vomiting, is growing for several reasons. A key factor is the rising incidence of conditions and treatments that cause these ...

The increasing demand for asthma treatment is largely driven by the rising number of asthma cases. Factors such as increased smoking and air pollution are impairing lung function and contributing to ...

One of the primary factors fueling the growth of the DOACs market is the rapid uptake and expected utilization within the ...

The Progressive Fibrosing Interstitial Lung Disease (PF-ILD) market is currently valued at USD 4,742.2 Million in 2023 and is ...

Global Pleural Diseases Therapeutics MarketThe global market for pleural diseases therapeutics is projected to experience ...

The Roundup covers notable class action decisions from federal appellate courts and notable Supreme Court class action cert petitions.

In other recent news, Pfizer Inc. is experiencing multiple developments. The pharmaceutical giant ... marking the second trial in which Boehringer Ingelheim, a marketer of Zantac, has not ...

(See US Department of Commerce & USPTO, Manual of Patent Examining Procedure § 1490(VI)(A); see also Boehringer Ingelheim Int ... Teva Pharm. USA, Inc., 566 F.3d 989, 999 (Fed.

While that Court's recent Allergan USA Inc. v ... invalidated under these circumstances, citing Boehringer Ingelheim Int'l GMBH v. Barr Labs., Inc., 592 F.3d 1340, 1348 (Fed.

The decision comes after the pharmaceutical giant announced ... A hung jury in Chicago marked the second trial where Boehringer Ingelheim, a marketer of Zantac, has not convinced a jury of the ...